Strategy for Ventures Where the Regulator is a Permanent Stakeholder
Over decades of handling and solving business problems, our team is able to advise and organize how to avoid problems and take advantage of opportunities. We advise founders, boards, and investors on the structural decisions that determine whether a licensed venture ever achieves its business plan.
Where Regulated Ventures Win or Lose Their First Three Years
Every engagement begins with a structured review across the five focus areas below. The result is a written strategic memorandum a founder or board can execute against — and share with lenders, licensing counsel, and regulators.
Regulatory Jurisdiction
Where a venture is domiciled and licensed shapes everything that follows. We map the jurisdictional options — federal, state, and municipal — against the client's operational and capital plan.
Capital Sources & Uses
Capital is the oxygen that all businesses use to breathe. We help operators identify equity, debt, and grant sources for deployment consistent with budgets and realistic expectations.
Industry Trends
Four decades on the frontier of emerging industry practice means we have watched multiple regulatory cycles land. We translate today's legal signals.
SWOT Analysis
A structured strengths, weaknesses, opportunities, and threats review — anchored in regulatory reality rather than generic strategy frameworks.
Team Building
Regulated ventures require operators who can speak with regulators. We advise on executive hiring, board composition, and outside advisor selection to meet that bar.
Psychedelic Medicine & Novel Bio-Therapies
We counsel domestic firms navigating the corporate development, capital structuring, and regulatory path for psychedelic medicine and novel bio-therapies. From U.S. drug development pipelines and FDA engagement to cross-border research compliance, we help operators advance treatments for PTSD, depression, and other emerging health therapies without running afoul of shifting state, federal, or international controls.
Our work spans entity formation, licensing strategy, research partnership agreements, and the compliance architecture required to sustain growth as the science — and the rules — evolve.